Company intelligence / Profile preview

Methinks AI

Ownership: Private
Development stage: Other

Overview

The company’s AI solution demonstrates high sensitivity and specificity for detecting large vessel occlusions and hemorrhages on non–contrast CT scans. It supports rapid triage and treatment decisions for acute stroke care. The technology has been deployed in research settings with positive results reported by clinicians. Recent funding rounds support further commercialization.

Therapeutic areas: NeurologyCardiovascular
Modalities: Device (AI-based medical imaging software)
Industry: Medical Imaging

Partnerships

Microsoft Teams integration for hospital workflowEuropean Innovation Council Fund investment partnershipEIT Health Catapult support

Beyond the preview

Go deeper on Methinks AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Methinks AI.

Explore the full profile